PFE vs TRU · P/E 20, rev $15.03B vs P/E 19, rev $4.58B
Pfizer Inc (PFE) versus TransUnion (TRU) — a side-by-side from cached financials, not a winner call.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
TransUnion (TRU) is a financial data & stock exchanges company listed on NYSE.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Latest reported TRU revenue for 2025-12-31 was $4.58B. Net income was $455.4M. Revenue was up 9.4% from 2024-12-31 to 2025-12-31. TRU currently screens at market cap $13.41B and trailing P/E 19.3.
PFE currently screens at market cap $147.73B and trailing P/E 19.8. TRU currently screens at market cap $13.41B and trailing P/E 19.3.
Not investment advice. Open the PFE and TRU stock pages for the full models.
Not investment advice.